Peter Hübener

469 total citations
12 papers, 239 citations indexed

About

Peter Hübener is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Peter Hübener has authored 12 papers receiving a total of 239 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hepatology, 8 papers in Epidemiology and 5 papers in Surgery. Recurrent topics in Peter Hübener's work include Liver Disease Diagnosis and Treatment (8 papers), Liver Disease and Transplantation (5 papers) and Liver Diseases and Immunity (5 papers). Peter Hübener is often cited by papers focused on Liver Disease Diagnosis and Treatment (8 papers), Liver Disease and Transplantation (5 papers) and Liver Diseases and Immunity (5 papers). Peter Hübener collaborates with scholars based in Germany, France and Switzerland. Peter Hübener's co-authors include Ansgar W. Lohse, Christoph Schramm, Christina Weiler‐Normann, Ye Htun Oo, Nwe Ni Than, Roman Zenouzi, Kornelius Schulze, Michael P. Manns, Henrike Lenzen and Michaël Bubenheim and has published in prestigious journals such as PLoS ONE, Alimentary Pharmacology & Therapeutics and Clinical Gastroenterology and Hepatology.

In The Last Decade

Peter Hübener

12 papers receiving 237 citations

Peers

Countries citing papers authored by Peter Hübener

Since Specialization

Citations

This map shows the geographic impact of Peter Hübener's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Hübener with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Hübener more than expected).

Fields of papers citing papers by Peter Hübener

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Hübener. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Hübener. The network helps show where Peter Hübener may publish in the future.

Co-authorship network of co-authors of Peter Hübener

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Hübener. A scholar is included among the top collaborators of Peter Hübener based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Hübener. Peter Hübener is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	High vaccination coverage and infection rate result in a robust SARS‐CoV‐2‐specific immunity in the majority of liver cirrhosis and transplant patients: A single‐center cross‐sectional study 2024 ·United European Gastroenterology Journal ·(unknown), (unknown), (unknown), Marc Lütgehetmann, (unknown), Sven Pischke, Felix Piecha, Andreas Drolz, (unknown), Peter Hübener, Malte H. Wehmeyer, Marylyn M. Addo, Lutz Fischer, Ansgar W. Lohse, Julian Schulze zur Wiesch, Martina Sterneck	1
2	Preoperative TIPS and in-hospital mortality in patients with cirrhosis undergoing surgery 2023 ·JHEP Reports ·Felix Piecha, (unknown), (unknown), (unknown), Ann‐Kathrin Ozga, (unknown), Daniel Benten, Peter Hübener, Matthias Reeh, Christoph Riedel, Peter Bannas, Jakob R. Izbicki, Gerhard Adam, Samuel Huber, Ansgar W. Lohse, Johannes Kluwe	9
3	Resolution of portal hypertension by insertion of a transjugular intrahepatic portosystemic shunt (TIPS) ameliorates markers of gut barrier function, systemic hyperinflammation and reverses phenotypic alterations of monocytes in patients with decompensated liver cirrhosis 2023 ·Zeitschrift für Gastroenterologie ·Felix Piecha, (unknown), (unknown), (unknown), (unknown), Gustav Buescher, (unknown), Daniel Benten, Christoph Riedel, Peter Buggisch, Peter Hübener, Samuel Huber, Ansgar W. Lohse, Peter Bannas, Lidia Bosurgi, Johannes Kluwe	1
4	Mini-laparoscopy as a diagnostic tool for abdominal tuberculosis: a retrospective series of 29 cases 2022 ·Surgical Endoscopy ·Thomas Theo Brehm, (unknown), Malte H. Wehmeyer, Martin Christner, Till S. Clauditz, Peter Hübener, Marylyn M. Addo, Ansgar W. Lohse, Stefan Schmiedel	2
5	A prospective pilot study of a gluten‐free diet for primary sclerosing cholangitis and associated colitis 2022 ·Alimentary Pharmacology & Therapeutics ·Timur Liwinski, (unknown), (unknown), Peter Hübener, Melina Heinemann, (unknown), (unknown), Bettina Jagemann, Rambabu Surabattula, Diana Julie Leeming, M.A. Karsdal, (unknown), Guido Schachschal, Thomas Rösch, Corinna Bang, André Franke, Ansgar W. Lohse, Detlef Schuppan, Christoph Schramm	12
6	Green tea extract–associated acute liver injury: Case report and review 2022 ·Clinical Liver Disease ·(unknown), (unknown), Olaf Boenisch, Peter Hübener, Stefan Kluge	8
7	Improvement of renal function prior to liver transplantation is not associated with better long-term renal outcome or survival 2021 ·Annals of Hepatology ·Thomas Horvatits, Peter Hübener, (unknown), (unknown), Lutz Fischer, Ansgar W. Lohse, Martina Sterneck	2
8	Das akut-auf-chronische Leberversagen als diagnostische und therapeutische Herausforderung der Intensivmedizin 2017 ·Medizinische Klinik - Intensivmedizin und Notfallmedizin ·Peter Hübener, Georg Braun, Valentin Fuhrmann	9
9	No Evidence That Azathioprine Increases Risk of Cholangiocarcinoma in Patients With Primary Sclerosing Cholangitis 2016 ·Clinical Gastroenterology and Hepatology ·Roman Zenouzi, Tobias J. Weismüller, Kristin Kaasen Jørgensen, Michaël Bubenheim, Henrike Lenzen, Peter Hübener, Kornelius Schulze, Christina Weiler‐Normann, Marcial Sebode, Hanno Ehlken, Nadine Pannicke, Johannes Hartl, Moritz Peiseler, (unknown), Tom H. Karlsen, Kirsten Muri Boberg, Michael P. Manns, Ansgar W. Lohse, Christoph Schramm	12
10	Validation of Transient Elastography and Comparison with Spleen Length Measurement for Staging of Fibrosis and Clinical Prognosis in Primary Sclerosing Cholangitis 2016 ·PLoS ONE ·Hanno Ehlken, (unknown), Christophe Corpechot, Lionel Arrivé, (unknown), Johannes Hartl, Susanne Lezius, Peter Hübener, Kornelius Schulze, Roman Zenouzi, Marcial Sebode, Moritz Peiseler, U Denzer, Alexander Quaas, Christina Weiler‐Normann, Ansgar W. Lohse, Olivier Chazouillères, Christoph Schramm	51
11	Efficacy of 6-Mercaptopurine as Second-Line Treatment for Patients With Autoimmune Hepatitis and Azathioprine Intolerance 2015 ·Clinical Gastroenterology and Hepatology ·(unknown), Ye Htun Oo, Nwe Ni Than, Peter Hübener, Christina Weiler‐Normann, Ansgar W. Lohse, Christoph Schramm	67
12	Low Risk of Hepatocellular Carcinoma in Patients With Primary Sclerosing Cholangitis With Cirrhosis 2014 ·Clinical Gastroenterology and Hepatology ·Roman Zenouzi, Tobias J. Weismüller, Peter Hübener, Kornelius Schulze, Michaël Bubenheim, Nadine Pannicke, (unknown), Henrike Lenzen, Michael P. Manns, Ansgar W. Lohse, Christoph Schramm	65

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact